Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name VIC-1911
Trade Name
Synonyms TAS-119|TAS-2104
Drug Descriptions

VIC-1911 (TAS-119) is a selective inhibitor of Aurora Kinase A, which potentially decreases tumor growth (Cancer Res 2023;83(7_Suppl):Abstract nr 429).

DrugClasses Aurka Inhibitors 26
CAS Registry Number NA
NCIT ID C116068


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Docetaxel + VIC-1911 Docetaxel VIC-1911 0 0
Paclitaxel + VIC-1911 Paclitaxel VIC-1911 0 0
Sotorasib + VIC-1911 Sotorasib VIC-1911 0 1
VIC-1911 VIC-1911 0 3

Additional content available in CKB BOOST